Sterile inflammation and pregnancy complications: a review

M Nadeau-Vallée, D Obari, J Palacios… - …, 2016 - rep.bioscientifica.com
Inflammation is essential for successful embryo implantation, pregnancy maintenance and
delivery. In the last decade, important advances have been made in regard to endogenous …

Placental apoptosis in health and disease

AN Sharp, AEP Heazell, IP Crocker… - American journal of …, 2010 - Wiley Online Library
Citation Sharp AN, Heazell AEP, Crocker IP, Mor G. Placental apoptosis in health and
disease. Am J Reprod Immunol 2010; 64: 159–169 Apoptosis, programmed cell death, is an …

Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18

G Ashoor, A Syngelaki, M Wagner, C Birdir… - American journal of …, 2012 - Elsevier
OBJECTIVE: The purpose of this study was to assess the prenatal detection rate of trisomy
21 and 18 and the false-positive rate by chromosome-selective sequencing of maternal …

Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks' gestation: effect of maternal and fetal factors

G Ashoor, L Poon, A Syngelaki, B Mosimann… - Fetal diagnosis and …, 2012 - karger.com
Objective: It was the aim of this study to examine the possible effects of maternal and fetal
characteristics on the fetal fraction in maternal plasma cell-free DNA (cfDNA) at 11–13 …

MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer

J Radojicic, A Zaravinos, T Vrekoussis, M Kafousi… - Cell cycle, 2011 - Taylor & Francis
miRNAs are small, regulatory molecules approximately 21-24 nucleotides in length. They
function at the post-transcriptional level by controlling the expression of more than 50% of …

Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes

LCY Poon, T Musci, K Song, A Syngelaki… - Fetal diagnosis and …, 2013 - karger.com
Objective: To examine the possible relationship between maternal and fetal characteristics
and pregnancy outcomes on fetal and maternal cell-free (cf) DNA in maternal plasma at 11 …

Cell-free nucleic acids as potential markers for preeclampsia

S Hahn, C Rusterholz, I Hösli, O Lapaire - Placenta, 2011 - Elsevier
Preeclampsia is one of the leading causes of maternal and fetal/neonatal mortality and
morbidity worldwide. Therefore, widely applicable and affordable tests are needed to make …

[HTML][HTML] DEGUM, ÖGUM, SGUM and FMF Germany recommendations for the implementation of first-trimester screening, detailed ultrasound, cell-free DNA screening …

P Kozlowski, T Burkhardt, U Gembruch… - Ultraschall in der …, 2019 - thieme-connect.com
Das Ersttrimester-Screening zwischen 11+ 0 und 13+ 6 Wochen mit qualifizierter Beratung,
differenzierter Organdiagnostik sowie maternalen und biochemischen Markern ist die …

[HTML][HTML] Absolute and relative quantification of placenta-specific microRNAs in maternal circulation with placental insufficiency–related complications

I Hromadnikova, K Kotlabova, J Doucha… - The Journal of Molecular …, 2012 - Elsevier
Placental insufficiency–related complications are one of the leading causes of maternal and
perinatal morbidity and mortality. This study investigated the quantification of placenta …

Pregnancy-related extracellular vesicles revisited

CE Condrat, VN Varlas, F Duică, P Antoniadis… - International journal of …, 2021 - mdpi.com
Extracellular vesicles (EVs) are small vesicles ranging from 20–200 nm to 10 μm in diameter
that are discharged and taken in by many different types of cells. Depending on the nature …